VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
137 hedge funds and large institutions have $376M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 12 closing their positions.
125% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 12
13% more capital invested
Capital invested by funds: $332M → $376M (+$44.3M)
12% more funds holding
Funds holding: 122 → 137 (+15)
5% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 42
23% less call options, than puts
Call options by funds: $3.65M | Put options by funds: $4.76M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$4.12M |
| 2 |
Rafferty Asset Management
New York
|
+$2.53M |
| 3 |
BlackRock
New York
|
+$2.3M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.83M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12.2M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.79M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.48M |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$993K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$930K |
VBIV Hedge Fund Activity: Q1 2021 in Review
137 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2021, worth a combined $376M — up 13% from $332M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new VBIV positions and 12 closed out — a net gain of 15 holders — while 44 added to existing stakes and 42 trimmed.
The largest buyer was Citigroup, adding an estimated $4.12M. The largest seller was State Street, cutting an estimated $12.2M.
- 137 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2021, up from 122 in Q4 2020.
- Funds reported $376M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2021, up 13% quarter-over-quarter.
- 27 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2021 and 12 closed out, a net change of +15 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2021 was Citigroup, an estimated $4.12M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2021 was State Street, an estimated $12.2M sold.
Based on aggregated 13F filings for Q1 2021.